PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar. MNajim@hamad.qa.\', \'Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.\', \'Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.\', \'Laboratory Department, Hamad Medical Corporation, Doha, Qatar.\', \'Nursing Department, Hamad Medical Corporation, Doha, Qatar.\', \'Infectious Diseases Department, Hamad Medical Corporation, Doha, Qatar.\', \'Medical Intensive Care Department, Hamad Medical Corporation, Doha, Qatar.\', \'Rheumatology Department, Hamad Medical Corporation, Doha, Qatar.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00296-021-04875-7
?:hasPublicationType
?:journal
  • Rheumatology international
is ?:pmid of
?:pmid
?:pmid
  • 33954813
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.906
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • Prevalence and clinical significance of antiphospholipid antibodies in patients with coronavirus disease 2019 admitted to intensive care units: a prospective observational study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all